Combination therapies are superior to monotherapy for many cancers. This advantage was
historically ascribed to the ability of combinations to address tumor heterogeneity, but …

Abstract Context Each year the European Association of Urology (EAU) produce a document
based on the most recent evidence on the diagnosis, therapy, and follow-up of testicular …

Testicular cancer is the most common malignancy among men between 14 and 44 years of
age, and its incidence has risen over the past two decades in Western countries. Both …

Testicular cancer is relatively uncommon and accounts for< 1% of all male tumors. However,
it is the most common solid tumor in men between the ages of 20 and 34 years, and the …

This selection from the NCCN Guidelines for Ovarian Cancer focuses on the less common
ovarian histopathologies (LCOHs), because new algorithms were added for LCOHs and …

Testicular Cancer — Discoveries and Updates | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …

Purpose To update the 2000 American Society of Clinical Oncology guideline on the use of
hematopoietic colony-stimulating factors (CSF). Update Methodology The Update …

Purpose To review the evidence on the incidence of long-term cardiac or pulmonary toxicity
secondary to chemotherapy, radiotherapy, or trastuzumab in symptomatic and asymptomatic …

The cytotoxic agent bleomycin is feared for its induction of sometimes fatal pulmonary
toxicity, also known as bleomycin-induced pneumonitis (BIP). The central event in the …

Plants, marine organisms, and microorganisms have evolved complex chemical defense
and signaling systems that are designed to protect them from predators and provide other …